Concord Medical Services Holdings Limited
Simbols: CCM
NYSE
0.52
USDTirgus cena šodien
-0.9214
P/E koeficients
0.0139
PEG koeficients
14.64M
MRK Cap
- 0.00%
DIV ienesīgums
Concord Medical Services Holdings Limited (CCM) Finanšu pārskati
Bilance
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 58.1 | 158.3 | 157.4 | ||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.net-receivables | 0 | 73.5 | 512.8 | 383 | ||||||||||||||||
balance-sheet.row.inventory | 0 | 40.3 | 84.8 | 38.1 | ||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 412.9 | 24.3 | 6 | ||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 617.2 | 759.8 | 584.5 | ||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 3734 | 3446.6 | 3347.7 | ||||||||||||||||
balance-sheet.row.goodwill | 0 | 575.4 | 575.4 | 581.9 | ||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 721.1 | 762.1 | 1074.7 | ||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 1296.6 | 1337.5 | 1656.6 | ||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 394.7 | 437.9 | 390.6 | ||||||||||||||||
balance-sheet.row.tax-assets | 0 | 5.1 | 0 | 237 | ||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 6.3 | 23.2 | 13.6 | ||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 5436.7 | 5245.1 | 5645.5 | ||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-assets | 0 | 6053.9 | 6004.9 | 6230 | ||||||||||||||||
balance-sheet.row.account-payables | 0 | 129.2 | 146.7 | 102.5 | ||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 1088.7 | 548.5 | 319.8 | ||||||||||||||||
balance-sheet.row.tax-payables | 0 | 17.1 | 28.8 | 21 | ||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 2207 | 2691.4 | 2412.8 | ||||||||||||||||
Deferred Revenue Non Current | 0 | 44.5 | 0 | 81.2 | ||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 674.1 | 325.2 | 301.1 | ||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 2355.6 | 2868 | 2681.7 | ||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 239.5 | 235.9 | 234.7 | ||||||||||||||||
balance-sheet.row.total-liab | 0 | 4307 | 3989.3 | 3486.2 | ||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.common-stock | 0 | 0.1 | 0.1 | 0.1 | ||||||||||||||||
balance-sheet.row.retained-earnings | 0 | -4064.6 | -3766.9 | -3277.3 | ||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | -65.4 | -27.8 | -29.5 | ||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 2008 | 1930.6 | 1936.5 | ||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | -2121.9 | -1864 | -1370.1 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 6053.9 | 6004.9 | 6230 | ||||||||||||||||
balance-sheet.row.minority-interest | 0 | 3868.9 | 3879.6 | 4113.8 | ||||||||||||||||
balance-sheet.row.total-equity | 0 | 1747 | 2015.7 | 2743.7 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||||||
Total Investments | 0 | 394.7 | 437.9 | 390.6 | ||||||||||||||||
balance-sheet.row.total-debt | 0 | 3295.7 | 3239.9 | 2732.7 | ||||||||||||||||
balance-sheet.row.net-debt | 0 | 3237.6 | 3081.6 | 2575.3 |
Naudas plūsmas pārskats
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -769 | -522.7 | -404 | |||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 132.8 | 104.1 | 80.3 | |||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -71.8 | 11.3 | -13.3 | |||||||||||||||
cash-flows.row.stock-based-compensation | 0 | -5.9 | 14.7 | 20.6 | |||||||||||||||
cash-flows.row.change-in-working-capital | 0 | 105 | -46.6 | -32.6 | |||||||||||||||
cash-flows.row.account-receivables | 0 | 0.6 | -64.5 | -6.2 | |||||||||||||||
cash-flows.row.inventory | 0 | -46.8 | -4.4 | -14.4 | |||||||||||||||
cash-flows.row.account-payables | 0 | 113.7 | 262.8 | 11.1 | |||||||||||||||
cash-flows.row.other-working-capital | 0 | 37.4 | -240.6 | -23.1 | |||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 392.2 | 79.9 | 119.3 | |||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -384.8 | -780.3 | -512.9 | |||||||||||||||
cash-flows.row.acquisitions-net | 0 | -2.3 | -66 | 62.4 | |||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 209.1 | -108.5 | |||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 11.9 | 20 | -7.9 | |||||||||||||||
cash-flows.row.other-investing-activites | 0 | 256.4 | 51.2 | 33 | |||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -118.8 | -566 | -533.9 | |||||||||||||||
cash-flows.row.debt-repayment | 0 | -394.6 | -230.8 | -1271 | |||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.other-financing-activites | 0 | 777.7 | 873.2 | 2409.3 | |||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 383.1 | 642.4 | 1138.3 | |||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | -47.2 | -4.6 | -2.6 | |||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 0.4 | -287.5 | 372.1 | |||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 159.3 | 158.9 | 446.4 | |||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 158.9 | 446.4 | 74.3 | |||||||||||||||
cash-flows.row.operating-cash-flow | 0 | -216.7 | -359.3 | -229.8 | |||||||||||||||
cash-flows.row.capital-expenditure | 0 | -384.8 | -780.3 | -512.9 | |||||||||||||||
cash-flows.row.free-cash-flow | 0 | -601.5 | -1139.6 | -742.7 |
Peļņas vai zaudējumu aprēķina rinda
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 537.4 | 472.1 | 485.6 | ||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 614 | 624.5 | 542.5 | ||||||||||||||||
income-statement-row.row.gross-profit | 0 | -76.6 | -152.4 | -56.9 | ||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.other-expenses | 0 | -10.8 | -216.6 | -1.2 | ||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 386.4 | 372.6 | 401.4 | ||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 1000.4 | 997.1 | 944 | ||||||||||||||||
income-statement-row.row.interest-income | 0 | 10.8 | 10 | 5.9 | ||||||||||||||||
income-statement-row.row.interest-expense | 0 | 165.7 | 120.4 | 73.8 | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 62.2 | -314.8 | -70.9 | ||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | -10.8 | -216.6 | -1.2 | ||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 62.2 | -314.8 | -70.9 | ||||||||||||||||
income-statement-row.row.interest-expense | 0 | 165.7 | 120.4 | 73.8 | ||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 128.5 | -56.1 | 126.9 | ||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.operating-income | 0 | -463 | -525 | -458.3 | ||||||||||||||||
income-statement-row.row.income-before-tax | 0 | -555.6 | -839.9 | -529.2 | ||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | -24.6 | -70.9 | -6.6 | ||||||||||||||||
income-statement-row.row.net-income | 0 | -297.7 | -769 | -522.7 |
Biežāk uzdotie jautājumi
Kas ir Concord Medical Services Holdings Limited (CCM) kopējie aktīvi?
Concord Medical Services Holdings Limited (CCM) kopējie aktīvi ir 6053943000.000.
Kādi ir uzņēmuma gada ieņēmumi?
Gada ieņēmumi ir N/A.
Kāda ir uzņēmuma peļņas norma?
Uzņēmuma peļņas norma ir -0.142.
Kāda ir uzņēmuma brīvā naudas plūsma?
Brīvā naudas plūsma ir -26.194.
Kāda ir uzņēmuma neto peļņas norma?
Neto peļņas norma ir -0.553.
Kādi ir uzņēmuma kopējie ieņēmumi?
Kopējie ieņēmumi ir -0.861.
Kāda ir Concord Medical Services Holdings Limited (CCM) tīrā peļņa (tīrie ienākumi)?
Tīrā peļņa (tīrie ienākumi) ir -297658000.000.
Kāds ir uzņēmuma kopējais parāds?
Kopējais parāds ir 3295701000.000.
Kāds ir pamatdarbības izdevumu skaits?
Darbības izdevumi ir 386377000.000.
Kāds ir uzņēmuma skaidrās naudas rādītājs?
Uzņēmuma nauda ir 0.000.